BioSpace News Archive

MilliporeSigma today unveiled its BioContinuum™ Buffer Delivery Platform, a new building block in the BioContinuum™ Platform for next-generation bioprocessing, at INTERPHEX in New York City

Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today announced that its Myriad Women’s Health business unit will present results from two important studies at the 2019 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting that highlight the performance of its prenatal tests.

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Health Insurance Innovations, Inc.

On April 2nd, Berks Heim nursing home employees represented by United Food & Commercial Workers Local 1776 Keystone State overwhelmingly approved a new five-year contract agreement that preserves long-term, quality resident care and ensures long-term job security for hundreds of Berks Heim members who serve the Berks County community.

Provides Flexibility to Execute on Aurora’s Global Expansion and Partnering Strategy

EspeRare, a not-for-profit organization dedicated to accelerating the development of rare diseases treatments, today announced that it has entered into an agreement with Dermelix Biotherapeutics for the co-development of its lead programme, DMX-101.

Imvax, Inc., a clinical-stage biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies, today announced positive results from an ongoing Phase 1b clinical trial that demonstrate treatment with IGV-001, the Company’s novel autologous tumor cell vaccine, outperformed standard of care (SOC) with prolonged overall survival (OS) and progression-free survival (PFS) in patients with newly diagnosed glioblastoma multiforme (GBM)

Tour celebrates 50th anniversary of ‘flower power’ and shares the stress-relieving benefits of blooms

The Los Angeles Biomedical Research Institute (LA BioMed) today held the grand opening of its new state-of-the-art medical research building and bioscience incubator on its campus at Harbor-UCLA Medical Center in Torrance.

As a global leading supplier of antibodies, small molecule conjugates and critical assay reagents for bio-technology industry, Creative Diagnostics today announced the launch of a series of innovative food analysis products and services for global customers, which can be applied for industries including dairy, honey, cereals, meat, seafood, beverages, fruits, spices & nuts, and water quality.